Sari Atula
Overview
Explore the profile of Sari Atula including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Myllynen C, Tuulasvaara A, Atula S, Laakso S
Eur J Neurol
. 2024 Oct;
31(12):e16522.
PMID: 39435628
Background And Purpose: Exacerbation of myasthenia gravis (MG) with respiratory failure requires intensive care. We aimed to study the risk factors for intensive care unit admission for MG exacerbation and...
2.
Piehl F, Vissing J, Mehtala J, Berggren F, Lindberg-Schager I, Pitsi D, et al.
Eur J Neurol
. 2024 Oct;
31(12):e16511.
PMID: 39380430
Background And Purpose: Health care resource utilization (HCRU) and the economic burden of myasthenia gravis (MG) are significant, but existing studies rarely include comprehensive nationwide data. We examined HCRU and...
3.
Vissing J, Atula S, Savolainen M, Mehtala J, Mehkri L, Olesen T, et al.
J Neurol Neurosurg Psychiatry
. 2024 Mar;
95(10):919-926.
PMID: 38538059
Background: Incidence and prevalence rates of myasthenia gravis (MG) vary considerably across studies, and mortality risk is rarely addressed. We examined the prevalence and incidence rates, mortality and factors associated...
4.
Myllynen C, Sarkkinen J, Atula S, Tienari P, Kekalainen E, Laakso S
Immunol Lett
. 2023 Jul;
260:81-88.
PMID: 37414259
Myasthenia gravis (MG) is an autoantibody-mediated neuromuscular disease with an unpredictable clinical course. Serum free light chains (FLCs) have risen as a promising biomarker for MG, but their role in...
5.
Maunula A, Martola J, Atula S, Laakso S, Tienari P
Eur J Neurol
. 2023 May;
30(8):2376-2384.
PMID: 37158298
Background And Purpose: There is an absence of data from large population-based cohort studies on the incidence of radiologically isolated syndrome (RIS). The incidence of RIS and the subsequent risk...
6.
Rauma I, Viitala M, Kuusisto H, Atula S, Sipila J, Ryytty M, et al.
Mult Scler Relat Disord
. 2022 Apr;
61:103755.
PMID: 35483129
Background: Cladribine tablets for adult patients with highly active relapsing multiple sclerosis (MS) have been available in Finland since 2018. Real-world data from different genetic and geographical backgrounds are needed...
7.
Sarkkinen J, Dunkel J, Tuulasvaara A, Huuskonen A, Atula S, Kekalainen E, et al.
Mod Pathol
. 2022 Mar;
35(9):1168-1174.
PMID: 35338262
The ability of thymic histopathology to predict the long-term impact of thymectomy in non-thymomatous myasthenia gravis (NTMG) is mainly uncharted. We applied digital pathology to quantitatively characterize differences of thymic...
8.
Mustonen T, Sivonen V, Atula S, Kiuru-Enari S, Sinkkonen S
Orphanet J Rare Dis
. 2021 Oct;
16(1):448.
PMID: 34689817
Background: Gelsolin amyloidosis (AGel amyloidosis) is a hereditary form of systemic amyloidosis featuring ophthalmological, neurological and cutaneous symptoms. Previous studies based mainly on patients' self-reporting have indicated that hearing impairment...
9.
Laakso S, Myllynen C, Strbian D, Atula S
J Neurol Sci
. 2021 Jun;
427:117549.
PMID: 34167051
Background: The effect of comorbidities on the prognosis of myasthenia gravis (MG) remains unclear. In particular, the role of other autoimmune diseases (AD) is controversial. Methods: In this retrospective single-center...
10.
Mustonen T, Holkeri A, Holmstrom M, Atula S, Pakarinen S, Lehmonen L, et al.
Amyloid
. 2021 Apr;
28(3):168-172.
PMID: 33877023
Introduction: Finnish gelsolin amyloidosis (AGel amyloidosis) is an inherited systemic amyloidosis with well-known ophthalmological, neurological and cutaneous symptoms. Additionally, cardiomyopathies, conduction disorders and need of cardiac pacemakers occur in some...